A03245 | Pages: NA | Jul 2022 | 6323 Views | | |
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Cold Remedies Market
Request Now !Cold is an infectious disease that affects the respiratory system. The common symptoms for cold include sneezing, sore throat, a stuffy nose, and coughing. Cold remedies are used to treat cold in immunosuppressed individuals. The composition of many cold medicines are same and therefore taking too much of certain medication can lead to drug resistance or serious injury.
Rise in geriatric population, demand for effective combination products, and switch from Rx to OTC category drive the market. However, competition faced by international players due to drugs from local manufacturers and natural remedies restrain the market growth. Favorable regulations and opportunities in the emerging economies of Asia-Pacific and LAMEA due to availability of large patient pools provide growth prospects for the market.
The report segments the global cold remedies market based on drug type, dosage type, end user, and region. Based on drug type, it is divided into antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Based on dosage type, it is classified into oral syrups, tablets/pills, nasal drops, lozenges, and others.
By distribution channel, it is categorized into hospital pharmacies, retail pharmacies, drug stores, supermarkets/hypermarkets, and e-commerce/online pharmacies. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Key players operating in the market include Reckitt Benckiser Group plc, Johnson & Johnson, GlaxoSmithKline plc, Novartis AG, Bayer AG, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Pfizer Inc., Prestige Brands Holdings, Inc., and Procter & Gamble Co.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 COLD REMEDIES MARKET, BY DRUG TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ANTIHISTAMINES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. EXPECTORANTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. BRONCHODILATORS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. DECONGESTANTS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. ANTIBIOTICS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. OTHERS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
CHAPTER 5 COLD REMEDIES MARKET, BY DOSAGE TYPE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ORAL SYRUPS
5.2.1. Market size and forecast
5.3. TABLETS/PILLS
5.3.1. Market size and forecast
5.4. NASAL DROPS
5.4.1. Market size and forecast
5.5. LOZENGES
5.5.1. Market size and forecast
5.6. OTHERS
5.6.1. Market size and forecast
CHAPTER 6 COLD REMEDIES MARKET, BY DISTRIBUTION CHANNEL
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITAL PHARMACIES
6.2.1. Market size and forecast
6.3. RETAIL PHARMACIES
6.3.1. Market size and forecast
6.4. DRUG STORES
6.4.1. Market size and forecast
6.5. SUPERMARKETS/HYPERMARKETS
6.5.1. Market size and forecast
6.6. E-COMMERCE/ONLINE PHARMACIES
6.6.1. Market size and forecast
CHAPTER 7 COLD REMEDIES MARKET, BY REGION
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.2.4. North America Cold Remedies Market by Drug Type
7.2.5. North America Cold Remedies Market by Dosage Type
7.2.6. North America Cold Remedies Market by Distribution Channel
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast
7.3.4. Europe Cold Remedies Market by Drug Type
7.3.5. Europe Cold Remedies Market by Dosage Type
7.3.6. Europe Cold Remedies Market by Distribution Channel
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Rest of Asia-Pacific market size and forecast
7.4.4. Asia-Pacific Cold Remedies Market by Drug Type
7.4.5. Asia-Pacific Cold Remedies Market by Dosage Type
7.4.6. Asia-Pacific Cold Remedies Market by Distribution Channel
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. Saudi Arabia market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast
7.5.4. LAMEA Cold Remedies Market by Drug Type
7.5.5. LAMEA Cold Remedies Market by Dosage Type
7.5.6. LAMEA Cold Remedies Market by Distribution Channel
CHAPTER 8 COMPANY PROFILES
8.1. RECKITT BENCKISER GROUP PLC
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. JOHNSON & JOHNSON
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. GLAXOSMITHKLINE PLC.
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. NOVARTIS AG
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. BAYER AG
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. ASTRAZENECA PLC
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. SUN PHARMACEUTICAL INDUSTRIES LTD.
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. PFIZER INC.
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. PRESTIGE BRANDS HOLDINGS, INC.
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. PROCTER & GAMBLE CO.
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers